Gentamicin substrate-labeled fluorescent immunoassay containing monoclonal antibody.
AUTOR(ES)
Place, J D
RESUMO
The current substrate-labeled fluorescent immunoassay for gentamicin has been modified by substituting monoclonal antibodies for conventional antiserum to gentamicin. The standard curve generated with gentamicin monoclonal antibody was essentially linear from 0 to 12 micrograms/ml, could detect 0.4 micrograms of gentamicin per ml, and had overall intra- and interassay precision values (coefficients of variation) of 1.9 and 5.0%, respectively. The substrate-labeled fluorescent immunoassay produced with gentamicin monoclonal antibody gave results with clinical specimens comparable (r = 0.991) to those obtained with the commercially available substrate-labeled fluorescent immunoassay and also with an enzyme immunoassay, a radioimmunoassay, and a fluorescent immunoassay. This technologically state-of-the-art assay employs both a nonisotopic label and monoclonal antibodies. It offers excellent precision, sensitivity, lot-to-lot reproducibility, linearity, and reagent stability.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185146Documentos Relacionados
- Substrate-labeled fluorescent immunoassay for amikacin in human serum.
- Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
- Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.
- Confirmation of Legionella pneumophila cultures with a fluorescein-labeled monoclonal antibody.
- A microplate enzyme-immunoassay for toxoplasma antibody.
